BIO 2015: DuPont counsel shares best practices for protecting trade secrets

Recent patent decisions in the life sciences sector are leading biotechnology companies to seek protection for their innovations by using alternatives to patents, with trade secrets the most viable, the BIO International Convention has heard.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

UK-India trade deal is ‘missed opportunity’, say industry bodies

SEPs now searchable on WIPO’s global patent database

INTA 2025: San Diego to host largest post-COVID Annual Meeting

'Nothing can stand in the way of our work': Ukraine resumes IP system

Foley adds five-partner team from Perkins Coie and K&L Gates

WATCH: Finding a new balance in IP protection with trade secret protection

Optis v Apple: How the court calculated the royalty rate

Cahill expands practice with three-partner team from King & Spalding

BIO 2015: DuPont counsel shares best practices for protecting trade secrets

Editor's picks

Editor's picks

More articles